atbody atbodies are rapidly produced bifunctional antibodies combining multiple targeting and killing domains, enhancing their effectiveness and safety compared to tradictional conjugates. Their unique composition aims to generate increased potency, stability and superior targeted exposure aiming to treat hematological malignancies, solid tumors and auto-immune disease. Thanks to their novel mechanism of action, atbodies can deliver transformative therapies to patient worldwide atbiofarm Our patented and versatile plant-based atbiofarm technology enables single-step manufacturing of our game-changer atbodies. This disruptive technology enables shorter development timelines, increasing the speed to clinic, and avoids chemical linker issues.